• TCS reported a 10.98% YoY rise in its consolidated Q3 net profit at Rs 10,883 cr. • Consolidated revenue from operations came in at Rs 58,229 cr, up 19.11%. • In constant currency terms, the revenue rose 13.5% YoY.
Lupin and Exeltis got approval from Spanish Government for reimbursement of Namuscla (Mexiletine), which is used for the symptomatic treatment of Myotonia.
• December total toll collection was up 6% MoM at Rs 388 cr vs Rs 365.9 cr • December total toll collection was up 31.9% YoY at Rs 388 cr vs Rs 294.1 cr
Check More Details